Company news

Royalty Pharma plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics’ Royalty on Evrysdi

October 18, 2023

Royalty Pharma Declares Fourth Quarter 2023 Dividend

October 15, 2023

Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023

October 10, 2023

Royalty Pharma Appoints Eric Schneider as Chief Technology Officer

September 20, 2023

Royalty Pharma and Ferring Pharmaceuticals Enter into US $500 million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin® (nadofaragene firadenovec-vncg)

August 23, 2023

Royalty Pharma and Ferring Pharmaceuticals Enter Into US $500 Million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin® (Nadofaragene Firadenovec-Vncg)

August 23, 2023

Royalty Pharma Reports Second Quarter 2023 Results

August 7, 2023

Royalty Pharma to Announce Second Quarter 2023 Financial Results on August 8, 2023

July 17, 2023

Royalty Pharma Declares Third Quarter 2023 Dividend

July 16, 2023

Royalty Pharma to Present at the Goldman Sachs 44th Annual Global Healthcare Conference

June 6, 2023

Royalty Pharma Reports First Quarter 2023 Results

May 8, 2023

Royalty Pharma To Present At The BofA Securities 2023 Health Care Conference

May 2, 2023

Royalty Pharma Declares Second Quarter 2023 Dividend

April 16, 2023

Royalty Pharma to Announce First Quarter 2023 Financial Results on May 9, 2023

April 12, 2023

Royalty Pharma Announces $1.0 Billion Share Repurchase Program

March 26, 2023

Royalty Pharma and PureTech Health Enter Into KarXT Royalty Agreement for Up to $500 Million

March 22, 2023

PureTech Health and Royalty Pharma Enter into KarXT Royalty Agreement for up to $500 Million

March 22, 2023

Royalty Pharma Raises Full Year 2023 Guidance

March 14, 2023

Royalty Pharma Appoints Ashwin Pai as Executive Vice President, Investments

February 28, 2023

Royalty Pharma Reports Q4 and Full Year 2022 Results

February 14, 2023

Royalty Pharma To Announce Fourth Quarter And Full Year 2022 Financial Results On February 15, 2023

January 17, 2023

Royalty Pharma Highlights Accomplishments and Provides Business Update at 41st Annual J.P. Morgan Healthcare Conference

January 8, 2023

Royalty Pharma and Ionis Enter Into Royalty Agreement for Up to $1.1 Billion to Further Advance Ionis’ Genetic Medicines and Commercial Readiness

January 8, 2023

Ionis and Royalty Pharma enter into royalty agreement for up to $1.1 billion to further advance Ionis' genetic medicines and commercial readiness

January 8, 2023

Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 9

January 3, 2023

Royalty Pharma Announces Expansion of Senior Leadership Team

December 14, 2022

Royalty Pharma to Present at Evercore ISI 5th Annual HealthCONx Virtual Conference

November 27, 2022

Royalty Pharma Agrees to Acquire Royalty Interest in Olpasiran From Arrowhead for $250 million and Future Milestones

November 8, 2022

Royalty Pharma Reports Third Quarter 2022 Results

November 7, 2022

Royalty Pharma to Announce Third Quarter 2022 Financial Results on November 8, 2022

October 17, 2022

Royalty Pharma Declares Fourth Quarter 2022 Dividend

October 16, 2022

Royalty Pharma Announces R&D Funding Collaboration With Merck

October 11, 2022

Royalty Pharma Announces Expansion of Leadership Team

October 11, 2022

Royalty Pharma Reports Second Quarter 2022 Results

August 3, 2022

Royalty Pharma Declares Third Quarter 2022 Dividend

July 14, 2022

Royalty Pharma to Announce Second Quarter 2022 Financial Results on August 4, 2022

July 13, 2022

Royalty Pharma Agrees to Acquire Royalty Interest in TRELEGY ELLIPTA From Theravance and Innoviva for $1.31 Billion and Potential Milestones of $300 Million

July 12, 2022

Royalty Pharma Acquires Royalty Interest in Gavreto From Blueprint Medicines for up to $340 Million

June 29, 2022

Royalty Pharma to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference

June 7, 2022

Royalty Pharma to Present at the UBS Global Healthcare Conference 2022

May 22, 2022

Royalty Pharma Investor Day Highlights Stronger Growth Outlook and the Power of Its Unique Business Model to Drive Value for All Stakeholders

May 16, 2022

Royalty Pharma Reports First Quarter 2022 Results

May 4, 2022

Royalty Pharma Declares Second Quarter 2022 Dividend

April 17, 2022

Royalty Pharma to Announce First Quarter 2022 Financial Results on May 5, 2022

April 12, 2022

Royalty Pharma Announces Charitable Alliance with The Leukemia & Lymphoma Society (LLS) To Advance Initiatives that Address Healthcare Disparities in Blood Cancer Care and Treatment

March 28, 2022

Royalty Pharma to Present at Cowen's 42nd Annual Health Care Conference

March 2, 2022

Royalty Pharma Announces Inaugural Investor Day

February 15, 2022

Royalty Pharma Reports Q4 and Full Year 2021 Results

February 14, 2022

Royalty Pharma to Announce Fourth-Quarter and Full-Year 2021 Financial Results on February 15, 2022

January 19, 2022

Royalty Pharma Highlights Accomplishments and Provides Business Update at 40th Annual J.P. Morgan Healthcare Conference

January 9, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 60 decks. Every deck is listed under its year.